Replimune Presents Late-Breaking Abstract Featuring Data from IGNYTE Clinical Trial of RP1 Combined with Nivolumab in Anti-PD1 Failed Melanoma at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC 2024)
November 09, 2024 13:00 ET | Source: Replimune Group Inc Oral presentation…
SEALSQs Secure Digital Identity Ecosystem, Designed to Fortify 5G Networks Against Cyber Threats, Safeguards User Privacy and Upholds Data Sovereignty
November 08, 2024 09:10 ET | Source: SEALSQ Geneva, Switzerland, Nov. 08,…
AI adoption accelerates across Asia Pacific, strategic data management remains key: New Digital Realty study
Robust and sustainable infrastructure essential to maximize AI investments SINGAPORE, Nov. 4,…
Celebrating 25 Years of Sculptra: New Data and Recent Approval in China Cements Galdermas Leadership in Regenerative Biostimulation
Galderma celebrates the 25th anniversary of the approval of Sculptra®, the first…
OnKure to Present Clinical and Preclinical Data for OKI-219 at the 2024 San Antonio Breast Cancer Symposium
November 01, 2024 17:30 ET | Source: OnKure Therapeutics, Inc. OnKure to…